Yuanqian Yao
Nanning, 530000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Bioinformatic characterization of SLC25A39 across cancers with validation in hepatocellular carcinoma.
Journal: Discover oncology
Published: February 17, 2026
Correction: Multidimensional analysis reveals the potential of ACSL3 as a cancer biomarker: from pan-cancer exploration to functional validation in hepatocellular carcinoma.
Journal: Clinical and experimental medicine
Published: November 25, 2025
The role of PD‑1/PD‑L1 axis in liver diseases.
Journal: Clinical and experimental medicine
Published: October 07, 2025
Global burden and forecast of infectious diseases attributable to drug use: evidence from GBD 2021.
Journal: Frontiers in public health
Published: September 16, 2025
Comprehensive pan-cancer characterization of IRAK2 as a potential prognostic biomarker and therapeutic target with validation in hepatocellular carcinoma.
Journal: BMC cancer
Published: September 05, 2025
Multidimensional analysis reveals the potential of ACSL3 as a cancer biomarker: from pan-cancer exploration to functional validation in hepatocellular carcinoma.
Journal: Clinical and experimental medicine
Published: August 19, 2025
Qizhu Rougan Granules suppress liver fibrosis by inhibiting the expression of the P2Y14 receptor on hepatic stellate cells.
Journal: Frontiers in pharmacology
Published: November 14, 2024
Multi-omics analysis and validation of the tumor microenvironment of hepatocellular carcinoma under RNA modification patterns.
Journal: Mathematical biosciences and engineering : MBE
Published: December 05, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026